Assessment of subclinical atherosclerosis to improve prevention of coronary artery disease

点击翻译按钮获取中文摘要

To prevent heart disease, we currently treat many patients with statins based on their risk factors. Improving risk prediction by combining tests that identify pre-symptomatic disease (like other screening programs) can better identify those most likely to benefit from statins and save healthcare costs. This study aims to determine if this screening strategy is cost-effective and warrants a change to the current approach of primary prevention of coronary heart disease in Australia.